Charles River Laboratories International Inc (NYSE:CRL)
$ 214.2 25.52 (13.53%) Market Cap: 10.95 Bil Enterprise Value: 13.50 Bil PE Ratio: 25.59 PB Ratio: 2.97 GF Score: 87/100

Charles River Laboratories International Inc at Wells Fargo Virtual Healthcare Conference Transcript

Sep 09, 2020 / 12:40PM GMT
Release Date Price: $209.89 (+3.42%)
Operator

Welcome to the Wells Fargo Healthcare Conference. Before we start, please note that Wells Fargo Securities events are by invitation only. Members of the press or media are not permitted to join. If you are a member of the press or media, please disconnect at this time. Also, please be advised that today's conference is being recorded. Thank you.

Daniel Louis Leonard;David Ross Smith
Wells Fargo Securities, LLC, Research Division - Senior Analyst;Charles River Laboratories International, Inc. - Corporate

Great. With that, hello, everybody. Thank you for joining us for the fireside chat today with Charles River. Joining us from the company are David Smith, CFO; and Todd Spencer from Investor Relations. I'm Dan Leonard, the Life Science Tools, Services and Diagnostics Analyst with Wells Fargo. The format is fireside chat. If you have a question for management, please raise your hand in Zoom or you can shoot me an e-mail and we'll try to address it.

And with that, I'll kick off the Q&A. Welcome, David and Todd.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot